References

COVID-19 vaccines for the low-income countries; challenges and the way forward

10.3126/jgmcn.v14i1.38081 · 2021 · External reference

Nanoparticles as adjuvants and nanodelivery systems for mRNA-based vaccines

10.3390/pharmaceutics13010045 · 2021 · External reference

The challenges of vaccine development against a new virus during a pandemic

10.1016/j.chom.2020.04.021 · 2020 · External reference

COVID-19 vaccines: rapid development, implications, challenges and future prospects

10.1007/s13577-021-00512-4 · 2021 · External reference

Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update

10.3389/fimmu.2021.658519 · 2021 · External reference

Genotype and phenotype of COVID-19: their roles in pathogenesis

10.1016/j.jmii.2020.03.022 · 2021 · External reference

Twenty-five years of the WHO vaccines prequalification programme (1987–2012): lessons learned and future perspectives

10.1016/j.vaccine.2013.11.066 · 2015 · External reference

Developing COVID-19 vaccines at pandemic speed

10.1056/nejmp2005630 · 2020 · External reference

Improving global access to new vaccines: intellectual property, technology transfer, and regulatory pathways

10.2105/ajph.2014.302236 · 2014 · External reference

Facilitating access to a COVID-19 vaccine through global health law

10.1177/1073110520958892 · 2020 · External reference

COVID-19 vaccine passports: access, equity, and ethics

10.1136/bmj.n861 · 2021 · External reference

Vaccine design and delivery approaches for COVID-19

10.1016/j.intimp.2021.108086 · 2020 · External reference

COVID-19: many poor countries will see almost no vaccine next year, aid groups warn

10.1136/bmj.m4809 · 2020 · External reference

Divergent COVID-19 vaccine policies: policy mapping of ten European countries

10.1016/j.vaccine.2023.03.036 · 2023 · External reference

Equitable access to COVID-19 vaccines: cooperation around research and production capacity is critical

10.1080/25751654.2021.1906591 · 2021 · External reference

L’Analyse qualitative des données

2009 · External reference

Recherche qualitative principes et méthodes

2019 · External reference

L’approche qualitative. Outils pratiques

2015 · External reference

Towards effective and efficient COVID-19 vaccination in Nigeria

10.29392/001c.21404 · 2021 · External reference

Considerations for establishing successful coronavirus disease vaccination programs in Africa

10.3201/eid2708.203870 · 2021 · External reference

Unresolved reference

2024 · External reference

The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response

10.1136/bmjgh-2021-007179 · 2021 · External reference

COVID-19 vaccine distribution: a review of strategies in Africa and the USA

10.30574/wjarr.2024.21.1.0381 · 2024 · External reference

Pandemic preparedness in Africa countries : status quo and the way forward

2025 · External reference

Leveraging AI to optimize vaccine supply chain and logistics in Africa: opportunities and challenges

10.3389/fphar.2025.1531141 · 2025 · External reference

Global governance for COVID-19 vaccines

10.1016/s0140-6736(20)31405-7 · 2020 · External reference

Access to and equitable distribution of COVID-19 vaccine in low-income countries

10.1038/s41541-021-00323-6 · 2021 · External reference

Unresolved reference

2024 · External reference

Perspectives and opportunities for precompetitive public-private partnerships in the biomedical sector

10.1089/blr.2013.9929 · 2013 · External reference

Innovative approaches to increase access to medicines in developing countries

10.3389/fmed.2017.00218 · 2017 · External reference

Vaccines : accelerating innovation and access global challenges report

2017 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2022 · External reference

African Vaccine manufacturing mapping: supply and demand landscape

2024 · External reference